Monashee Investment Management »

Karyopharm Therapeutics shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $35k 132k 0.26
2022-12-31 $1.6M 482k 3.40

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Structure Therapeutics Sponsored Ads (GPCR)
Aercap Holdings Nv SHS (AER)
PG&E Corporation (PCG)
Korro Bio (KRRO)
Eyepoint Pharmaceuticals Com New (EYPT)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)

View all positions for Monashee Investment Management

Top funds holding Karyopharm Therapeutics

Vanguard Group
Avidity Partners Management
Palo Alto Investors
Citadel Advisors
GSA Capital Partners
Marshall Wace
Bnp Paribas Arbitrage, Snc
Millennium Management
CAM Group Holding A/S
Deutsche Bank Aktiengesellschaft
Goldman Sachs Group
Jpmorgan Chase & Co
AlphaCentric Advisors
Tejara Capital
Barclays

View all funds holding Karyopharm Therapeutics